Skip to content
August 19, 2022

Equity.Guru

Investment information for the new generation

CMM.V

By the end of this article, you will buy stock in three companies. I will convince you this is a smart thing, because it is. Oh yeah. None of…
Emblem Corp (EMC.V) moved to enter the conversation with its customers and put its finger on the pulse of strain efficacy when Strainprint™ Technologies, a Toronto-based analytical software developer,…
This piece was written for and originally posted on Stockhouse, in partnership with Equity.Guru Last year, when the Pokemon Go app was launched across the world, Planet Earth was…
Canabo Medical (CMM.V) is poised to capitalize on the newest growth segment in the medical marijuana sector – big data. Chris Parry speaks with Advisory Board member, James Megann,…
Excuse the stereotypically clickbaity headline, if you would, because I think one of these will actually genuinely shock most readers. It shocked me when I came to the conclusion…
Twenty-five years ago, a drug overdose victim was typically from an inner city neighbourhood.  No longer. Like a cloud of mustard gas, drug addiction has swept across the manicured…
The weed business has one major bottleneck that screws up all business that comes before it. Wanna know what it is? It’s this: The positive effects of cannabis treatment…
Another day, another new cannabinoid clinic for the boffins at Canabo Medical (CMM.V): this one adding to their tally in Ontario with a new facility in the city of…
A few weeks back, Canabo Medical (CMM.V) faced a problem. Giant Canadian weed player, Aphria (APH.V), which had invested heavily in the company at $1.40 per share, sold a…
Much discussion was had over the weekend on various social media platforms as news dropped that Aphria had sold a chunk of their investment in weed referral clinic/data pile…